Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
07/2003
07/08/2003US6590093 Orthoester protecting groups
07/08/2003US6590084 Reacting 9-deoxo-9(E)-hydroxyiminoerythromycin A with a base in water, acidifying the mixture, adding an organic solvent, concentrating under vacuum, and isolating the desired stereoisomer; macrolide antibiotics
07/08/2003US6590083 Compounds of given formula; erythromycin derivatives; useful in the treatment of bacterial and protozoal infections and conditions involving gastric motility
07/08/2003US6589964 Method for enhancing mutant enzyme activities in lysosomal storage disorders
07/08/2003CA2286511C Novel macrolide derivatives
07/08/2003CA2254682C Method of treating eye infections with azithromycin
07/03/2003WO2003053988A2 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position
07/03/2003WO2003010116A3 Process for isolating phenolic compounds
07/03/2003WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures
07/03/2003WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
07/03/2003US20030125531 Arylation method for the functionalization of O-allyl erythromycin derivatives
07/03/2003US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound
07/03/2003US20030125267 A bicyclic heteroaromatic compound containing two keto, two ester, a carbamate groups and a methyl, hydroxy and amine substituted oxypyran ring; useful antibacterial agent for treating pneumonia, skin, soft tissue and bone infections
07/03/2003US20030125266 Administering a 14 membered macrolide and ketolide antibiotics containing C12 modifications to a patient suffering from bacterial infections
07/03/2003CA2469905A1 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position
07/02/2003EP1323726A1 Erythromycin derivatives and medicines containing the same
07/02/2003EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents
07/02/2003EP1175429B1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
07/01/2003US6586576 Preparation method of azithromycin hydrates
06/2003
06/26/2003WO2003051900A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer
06/26/2003WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same
06/26/2003WO2001097778A8 Amphotericin b structured emulsion
06/26/2003US20030120048 Process for producing purified erythromycin
06/26/2003US20030119874 Method for enhancing mutant enzyme activity in gaucher disease
06/26/2003US20030119761 Glycosyl CNS acting prodrug compound covalently N-linked with a saccharide through an amide or an amine bond; neuraxial drug delivery
06/26/2003US20030119759 Recovery of isoflavones from soy molasses
06/26/2003US20030118675 Recovery of isoflavones from soy molasses
06/26/2003US20030115687 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres
06/25/2003EP1250343B1 Azalide antibiotic compositions
06/25/2003CN1426301A Compositions for treatment and prevention of cardiovascular diseases
06/25/2003CN1425763A Use of icariin in inducing external oriented differentiation of embryo stem cells
06/25/2003CN1425674A Process for preparing astraglus base total saponin
06/24/2003US6583274 Crystalline forms of macrolide antibiotic
06/24/2003US6583158 Method for enhancing mutant enzyme activities in lysosomal storage disorders
06/24/2003US6583120 Erythromycin derivative with antibiotic activity
06/24/2003US6583119 Aromatic antibiotics such as 7-((6-deoxy-5-methyl-4-methyl-hexopyranosyl)oxy)-4-hydroxy-8-methyl-3-(1 -(phenoxyimino) ethyl)-2H-1-benzopyran-2-one (2-propynyloxy)-carbamic 3'-ester acid, for prevention of grampositive bacterial infections
06/24/2003US6583118 Chondroprotective agents
06/19/2003WO2003050132A1 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
06/19/2003US20030114396 Clarithromycin macrolides having enhanced activity towards gram-negative bacteria and macrolide resistant gram-positive bacteria; active against MLSB-resistant strains (MLSB=Macrolides-Lincosamides-type B Streptogramines)
06/19/2003US20030114395 Novel 11-O-substituted ketolide derivatives
06/19/2003US20030113290 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
06/19/2003CA2469304A1 6-o acyl ketolide antibacterials
06/18/2003CN1425022A Method for preparing 9-deoxo-8a-AZA-(8a-alkyl)-8a-homoerythromycin a derivatives from 9-deoxo-9 (Z)-hydroxyiminoerythromycin A
06/18/2003CN1424319A Extracts of cornus officinalis and its preparation and use
06/18/2003CN1111527C Sesquilterpenic internal ester compound for antiulcer of alimentary tract
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/17/2003US6579986 Preparation of quinoline-substituted carbonate and carbamate derivatives
06/17/2003US6579902 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048166A1 Podophyllotoxins as antiproliferative agents
06/12/2003WO2003047601A1 Novel 11-o-substituted ketolide derivatives
06/12/2003WO2003047600A1 11-o-substituted macrolides and their descladinose derivatives
06/12/2003US20030109489 Oligosaccharide derivatives and process for producing the same
06/12/2003US20030109463 Novel macrolides
06/12/2003US20030109462 Plants and insecticidal compositions comprising the naringenin derivatives as active components.
06/12/2003US20030108651 Therapeutic and anti-oxidant for variety of health purposes, including treatment of skin damage; also useful as a natural antibacterial, antiviral and fungicidal agricultural product
06/11/2003EP1318201A1 Process for producing purified anthocyanin and crystalline anthocyanin
06/11/2003EP1283821A4 A cost effective method for selective methylation of erythromycin a derivatives
06/11/2003CN1422856A Soybean isoflavone, soybean saponin and soybean oligosaccharide extraction method
06/10/2003US6577304 System and method for visually representing a supply chain
06/10/2003US6576749 C-4″-substituted macrolide derivatives
06/10/2003US6576615 Treatment and prevention of bacterial infections
06/10/2003US6576446 Process for producing high 2-O-α-D-glucopyranosyl-L-ascorbic acid
06/05/2003WO2003046194A1 NOVEL α-GALACTOSYL-CONTAINING NON-REDUCING DISACCHARIDES AND PROCESS FOR PRODUCING THE SAME
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003US20030104597 Recombinant narbonolide polyketide synthase
06/05/2003US20030104585 Gene clusters for formation of pipecolic acid for inclusion into rapamycins; polyketide synthases; immunosuppressants
06/04/2003EP0975648B1 Morphine derivatives
06/04/2003CN1422277A Novel substance having physiological activity, process for producing the same, and use
06/03/2003US6573367 Derivatives from the class of oleandomycin
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
05/2003
05/30/2003WO2003044209A1 Novel tetronic acid derivative
05/30/2003WO2003044208A1 Novel tetronic acid dervative
05/30/2003WO2003043642A1 Novel tylosin derivatives having antibacterial activity
05/30/2003CA2468046A1 Novel tetronic acid derivative
05/29/2003US20030100742 Erythromycin a derivatives
05/29/2003US20030100518 13-Methyl erythromycin derivatives
05/28/2003EP1314737A1 Process for producing erythromycin derivative
05/28/2003EP1313751A1 New macrolides with antibacterial activity
05/28/2003EP1313749A2 Process for preparation of anhydrous azithromycin
05/28/2003EP1313487A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
05/28/2003EP1313486A1 Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
05/28/2003EP1313449A2 Amphotericin b structured emulsion
05/28/2003EP1070077B1 15-membered lactams ketolides with antibacterial activity
05/28/2003CN1420122A Glycosides compound monomer in Chinese herbaceous peony, and method for extracting and separating same
05/27/2003US6569906 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase
05/27/2003US6569836 6-O-alkyl-2-nor-2-substituted ketolide derivatives
05/27/2003US6569443 Topical treatment or prevention of ocular infections
05/27/2003CA2387361C Crystal form 0 and form ii of clarithromycin and uses thereof
05/27/2003CA2387356C Crystal form 0 and form i of clarithromycin and uses thereof
05/27/2003CA2386534C Crystal form ii of clarithromycin and uses thereof
05/27/2003CA2386527C Crystal form i of clarithromycin
05/27/2003CA2277274C Crystal form 0 of clarithromycin
05/27/2003CA2268438C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
05/27/2003CA2258606C Crystal form ii of clarithromycin
05/22/2003WO2003042228A1 Macrolides
05/22/2003WO2002024146A3 Methods of decreasing or preventing pain using spicamycin derivatives
05/22/2003US20030096764 Novel Tylosin derivatives having antibacterial activity
05/22/2003US20030096763 4' -substituted leucomycins
05/22/2003US20030096335 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 117